Ultrasound-guided Peripheral Nerve Block Versus Forearm Bier's Block in Patients Undergoing Carpal Tunnel Release

March 26, 2020 updated by: Stessel Björn, Jessa Hospital

Efficacy of Ultrasound-guided Peripheral Nerve Block Versus Forearm Bier's Block in Patients Undergoing Carpal Tunnel Release: A Randomized Controlled Trial

By means of an observer-blinded, randomized controlled trial, the analgesic efficacy of the forearm intravenous regional anesthesia and the ultrasound guided peripheral nerve block will be investigated in patients undergoing carpal tunnel release. The hypothesis is that the ultrasound-guided peripheral nerve block is superior compared to the forearm intravenous regional anesthesia with respect to the analgesic efficacy.

Furthermore, pre-, intra-, and post-operative pain will be investigated at several time points as well as general patient satisfaction and satisfaction of the surgeon regarding the procedures.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Introduction:

In Belgium, several ways of anesthesia are used to perform hand surgery, being general anesthesia, intravenous regional anesthesia as well as locoregional anesthesia. Locoregional anesthesia and intravenous regional anesthesia are often performed since patients can be discharged from the hospital more rapidly. A forearm intravenous regional anesthesia (IVRA; mini-Bier's block) is an effective and safe technique to perform hand surgery, especially since the dose of the used anesthetic is reduced compared to a regular upper arm Bier's block, leading to a reduced risk of local anesthetic toxicity. An ultrasound-guided distal peripheral nerve block is often used for hand surgery, in which the nervus medianus and the nervus ulnaris can be affected locally. Research showed that this technique is associated with a reduced surgical procedure time when compared to intravenous regional anesthesia (1). In the Jessa Hospital, a carpal tunnel release is often performed using the forearm intravenous regional anesthesia. However, to date, the analeptic effectivity of the forearm intravenous regional anesthesia has not been compared to the distal peripheral nerve block.

Outcome measures:

The primary aim of this study is to compare the analgesic effectivity of the forearm intravenous regional anesthesia versus the ultrasound-guided distal peripheral nerve block. Our hypothesis is that the latter technique is superior. A blinded surgeon will determine the analgesic effectivity of these techniques (graded as "complete" or "incomplete") and divide the effectivity in 4 grades. Grade 1 and grade 2 are considered "complete" blockade, while grade 3 and grade 4 are considered "incomplete" blockade. Grade 1: complete motor and sensory blockade, grade 2: partial motor blockade but no pain or deep pressure sensitivity, grade 3: partial motor blockade with mild pain requiring rescue local or opioid analgesia, grade 4: incomplete motor- and sensory blockade requiring sedation/conversion to general anesthesia). Secondary study outcomes are patient's pre-, intra-, and post-operative pain scores at several time points, measured via an 11-point Numeric Rating Scale (NRS) in which number 0 means "no pain at all", number 5 means "moderate pain" and number 10 means "worst possible pain". General patient satisfaction as well as satisfaction of the surgeon regarding the used technique will be measured via a 7-point Likert Scale, in which number 1 means "extremely dissatisfied" and number 7 means "extremely satisfied". Furthermore, the time spend in the operating room, the time of surgical procedure and the use of post-operative medication use will be recorded as well.

Design:

In this monocentric, investigator-initiated, observer-blinded, prospective, randomized controlled trial, 2 groups of patients that will undergo carpal tunnel release surgery will be compared. This study will be performed according to the Declaration of Helsinki and will be approved by the Ethical Committee of the Jessa Hospital before the start of the study. A written informed consent will be obtained before participation in the study. Randomization will be performed using a computer-generated random allocation sequence, created by the study statistician. Allocation numbers will be sealed in opaque envelopes, which will be opened in sequence by an independent anaesthesiologist who is not involved in the assessment of outcomes.

Study Procedures:

The patient will first receive information about this study during the consultation with the surgeon. After having ample amount of time to consider participation and before the start of the study, written informed consent will be obtained. Afterwards, the patient will be randomized to one of the 2 study groups. All anesthesia techniques will be performed by only 2 anaesthesiologists, to reduce the inter-individual difference in anaesthesia. All patients will receive an intravenous catheter, supplementary oxygen and standard monitoring (non-invasive blood pressure, electrocardiogram and saturation measurements).

Forearm intravenous regional anesthesia:

An intravenous catheter will be placed in the dorsal vein of the hand that will undergo surgery. Also, a tourniquet will be placed on the forearm, after which the anesthetic can be administered via the dorsal vein catether (25ml linisol 0.5%).

Distal peripheral nerve block:

For the distal peripheral nerve block, a General Electric LOGIQe device and a 12 MHz lineair echotransducer with a foot of 4 cm will be used to locate the nervus medianus and the nervus ulnaris. In total, 10ml linisol 2% will be used to affect the nerves (3ml linisol 2% around the nervus medianus, 3ml linisol 2% around the nervus ulnaris and 4ml linisol 2% around the peripheral distal nerves).

The surgeon and the researcher will be blinded for the used type of anaesthesia. To reduce a possible deblinding, all patients receive a catheter in the dorsal vein of the hand that will undergo surgery and all patients will receive disinfection on the specific locations on the arm where the ultrasound-guided peripheral nerve block would be performed. In that way, both surgeon and researcher are blinded. Before the start of the surgery, the surgeon will assess the quality of the block (primary outcome) in the nervus ulnaris and nervus medianus, using a forceps. The quality of the block will be graded "complete" (grade 1 and grade 2) or "incomplete" (grade 3 or grade 4). In case of grade 1 or grade 2, the surgical procedure can start. In case of grade 3, the blockade will be enhanced (local anesthetic for peripheral nerve block or intravenous opioid administration (alfentanil or sufentanil) for IVRA). In case of grade 4, sedation/conversion to general anesthesia will be performed. Per-operative paracetamol administration 15mg/kg (max 1gram) and taradyl 0.5mg/kg (max 30mg) will be supplied (except when there are contraindications). All patients (both distal peripheral nerve block and IVRA) will receive dexamethasone 0.1mg/kg (max 5mg) (except when there are contraindications) due to the positive effect of dexamethasone on the extension of the locoregional anesthesia and the prevention of post-operative nausea and vomiting. All secondary outcome measures will be investigated by the blinded researcher via questioning the patient's pain scores (measured via an Numeric Rating Scale) at several time points before, during and after surgery, and the satisfaction of both patient and surgeon (measured via a 7-point Likert Scale). Post-operative pain medication in the hospital includes paracetamol 15mg/kg (max 1gr) 1x/6h and taradyl 0.5mg/kg (max 30mg) 1x/8h, while contramal serves as rescue medication. Post-operative pain medication at home includes paracetamol 15mg/kg (max 1gr) 1x/6h or ibuprofen 600mg 1x/8h whenever necessary. On day 1 after surgery, the patient will be contacted via telephone by the researcher who will question the use of post-operative pain medication, as well as NRS pain scores and patient satisfaction.

Statistical analysis:

Sample size was determined for the primary study outcome with the aim to reject the superiority of the distal peripheral nerve block compared to forearm intravenous regional anesthesia. Based on a retrospective analysis of unpublished data from our hospital, we assume that 75% of patients will have a complete block (grade 1 or2) after a forearm IVRA. Based on a previous study, we assume that 95% of patients will have a complete block (grade 1 or 2) after a distal peripheral nerve block (2). By using a binary outcome, we determined the sample size for each group to be 47 (α=0.05, power=0.80). To account for a possible 6% drop-out rate, the sample size was increased to 50 patients per group. Descriptive statistics will be presented as frequencies and percentages of the total amount of patients for categorical variables, while numerical variables will be presented as mean ± SD. Group comparison will be performed using Chi-square test (or a Fisher's Exact test when necessary) for frequencies. Depending on normality, a Mann-Witney U test or a Student's t-test will be used and a Mixed-model analysis will be used to correct for the multiple measurements of the Numerical Rating Scale (NRS) for pain scores. An average difference of 1.3 points or more on the NRS pain score is considered clinical relevant. A p-value <0.05 is considered statistical significant, while p<0.10 is considered a tendency.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Limburg
      • Hasselt, Limburg, Belgium, 3500
        • Jessa Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Males and females ≥ 18 years of age
  • American Society of Anesthesiology (ASA) physical status classification: 1-3
  • Patients planned to undergo carpal tunnel release via regional anesthesia (intravenous regional anesthesia or ultra-sound guided peripheral nerve block)

Exclusion Criteria:

  • Bilateral surgery
  • BMI ≥ 40 kg/m2
  • Infection in the area of the peripheral nerve block injection site
  • History of neurological conditions
  • Chronic pain symptoms
  • Concomitant use of Opioids in the last 3 months
  • Diabetes mellitus type-1 (insulin dependent diabetes mellitus)
  • Diabetes mellitus with organ damage
  • Oversensitivity to local anesthesia
  • Blood clotting disorder
  • History of any surgical procedure in the arm that needs to be operated
  • Inability to understand and adhere to the study design

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Forearm Bier's block
Forearm intravenous regional anesthesia (Bier's block)
The analgesic effectivity of the forearm intravenous regional anesthesia and the ultrasound-guided peripheral nerve block will be investigated in patients undergoing carpal tunnel release
Experimental: Peripheral Nerve Block
Ultrasound-guided peripheral nerve block (regional anesthesia)
The analgesic effectivity of the forearm intravenous regional anesthesia and the ultrasound-guided peripheral nerve block will be investigated in patients undergoing carpal tunnel release

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Analgesic effectivity
Time Frame: Intraoperative
This study wants to evaluate and compare the analgesic effectivity of the intravenous regional anesthesia (IVRA; mini-Bier's block) and the ultrasound-guided peripheral nerve block. The blinded surgeon will assess the analgesic effectivity and grade it as either complete (grade 1 and grade 2) or incomplete (grade 3 and grade 4). Grade 1 is defined as complete motor and sensory blockade; grade 2 is defined as partial motor blockade with no pain or deep pressure sensitivity. Grade 3 is defined as partial motor blockade with mild pain and the need for rescue local or opioid analgesia. Grade 4 is defined as incomplete motor and sensory blockade requiring sedation/conversion to general anesthesia.
Intraoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pre operative pain
Time Frame: Start of anesthesia technique
Pain score at start of anesthesia technique will be assessed via a Numerical Rating Scale (NRS). This scale is ranged (0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10) in which 0 stand for "no pain at all" and 10 for "worst pain possible".
Start of anesthesia technique
Pre operative pain
Time Frame: Intraoperative
Pain score at surgical incision (start of surgical procedure) will be assessed via a Numerical Rating Scale (NRS). This scale is ranged (0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10) in which 0 stand for "no pain at all" and 10 for "worst pain possible".
Intraoperative
Intra-operative: pain
Time Frame: Intraoperative
The pain score will be assessed over the period of the surgical procedure (which starts with the incision and ends with the closure of the surgical incision). The pain score will be assessed via a Numerical Rating Scale (NRS). This scale is ranged (0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10) in which 0 stand for "no pain at all" and 10 for "worst pain possible".
Intraoperative
Time in operating room
Time Frame: Intraoperative
Time patient is in operating room
Intraoperative
Time of surgical procedure
Time Frame: Intraoperative
Time of surgical procedure
Intraoperative
Post-operative pain
Time Frame: 1 day
Average pain score at hospital discharge and at day 1 after surgery will be assessed via a Numerical Rating Scale (NRS). This scale is ranged (0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10) in which 0 stand for "no pain at all" and 10 for "worst pain possible".
1 day
Use of post-operative pain medication
Time Frame: 1 day
The use of pain medication after surgery and at day 1 after surgery will be investigated and specified (type, dosage and frequency of medication)
1 day
Patient satisfaction
Time Frame: 1 day
General satisfaction of the patient with the anesthesia technique will be assessed via a 7-point Likert Scale. This scale is ranged (1, 2, 3, 4, 5, 6, 7) in which 1 stands for "completely dissatisfied" and 7 for "completely satisfied".
1 day
Surgeon satisfaction
Time Frame: 1 day
Satisfaction of the surgeon with the surgical conditions will be assessed via a 7-point Likert Scale. This scale is ranged (1, 2, 3, 4, 5, 6, 7) in which 1 stands for "completely dissatisfied" and 7 for "completely satisfied".
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Björn Stessel, MD, PhD, Jessa Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 17, 2018

Primary Completion (Actual)

December 20, 2019

Study Completion (Actual)

December 20, 2019

Study Registration Dates

First Submitted

January 11, 2018

First Submitted That Met QC Criteria

January 25, 2018

First Posted (Actual)

January 26, 2018

Study Record Updates

Last Update Posted (Actual)

March 27, 2020

Last Update Submitted That Met QC Criteria

March 26, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carpal Tunnel Syndrome

Clinical Trials on regional anesthesia

3
Subscribe